Mereo BioPharma Group (MREO) Consolidated Net Income: 2023-2025
Historic Consolidated Net Income for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to -$7.0 million.
- Mereo BioPharma Group's Consolidated Net Income rose 53.18% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.6 million, marking a year-over-year increase of 8.26%. This contributed to the annual value of -$43.3 million for FY2024, which is 46.79% down from last year.
- According to the latest figures from Q3 2025, Mereo BioPharma Group's Consolidated Net Income is -$7.0 million, which was up 51.94% from -$14.6 million recorded in Q2 2025.
- In the past 5 years, Mereo BioPharma Group's Consolidated Net Income ranged from a high of -$1.8 million in Q2 2023 and a low of -$15.0 million during Q3 2024.
- Over the past 3 years, Mereo BioPharma Group's median Consolidated Net Income value was -$9.1 million (recorded in 2023), while the average stood at -$9.7 million.
- Per our database at Business Quant, Mereo BioPharma Group's Consolidated Net Income crashed by 599.89% in 2024 and then soared by 53.18% in 2025.
- Mereo BioPharma Group's Consolidated Net Income (Quarterly) stood at -$9.1 million in 2023, then climbed by 22.65% to -$7.0 million in 2024, then spiked by 53.18% to -$7.0 million in 2025.
- Its Consolidated Net Income was -$7.0 million in Q3 2025, compared to -$14.6 million in Q2 2025 and -$12.9 million in Q1 2025.